Abstract:Recent advances in the fields of thromboinflammation and immunothrombosis induced a paradigm shift integrating platelets as key components of the immune system, independent of their hemostatic functions. Platelets constitutively express a plethora of immune receptors such as toll-like receptors (TLRs), complement receptors, antibody receptors (FcR), and intracellular NOD-like receptors (NLRs) and, upon activation, can also upregulate and secrete an arsenal of immunomodulatory molecules, regulating both the innate and adaptive immune responses [<a href="#">1</a>,<a href="#">2</a>]. Although platelets were initially shown to promote a proinflammatory and prothrombotic state in sterile and infectious injuries, recent studies have shown protective roles for platelets during inflammation, in particular in the maintenance of vascular integrity, resolution of inflammation, and promotion of tissue repair [<a href="#">3</a>,<a href="#">4</a>]. More recently, platelet microvesicles have emerged as novel regulators of thrombo-inflammatory diseases, which, unto themselves, can regulate both innate and adaptive immunity [<a href="#">5</a>,<a href="#">6</a>]. Inflammatory/immune alteration of platelet function does not occur solely in periphery, but might also result from transcriptional and translational alteration in the genetic profile of megakaryocytes. The pro- or anti-inflammatory functions of platelets are highly dynamic with distinct receptors engaged in different vascular beds during the course of the inflammatory response. Likewise, the composition and structure of thrombi under inflammatory conditions is highly heterogeneous, dictated directly by the specific nature of the insult and the characteristics of the target vascular bed/organ. Moreover, recent studies have shown significant changes in the composition of the thrombi within the same organ during disease progression, increasing the complexity of successful treatment under thromboinflammatory conditions without global alteration of the hemostatic balance. Therefore, the success of novel anti-thrombotic drugs or the strategic repurposing of existing therapies will need to be tailored to each stimulus, organ, and disease state in an effort to limit both thrombosis and inflammation while simultaneously preserving vascular integrity and organ function.

Platelet Interaction with Innate Immune Cells

Soluble CD40 Ligand Stimulates CD40-Dependent Activation of the Β2 Integrin Mac-1 and Protein Kinase C Zeda (pkcζ) in Neutrophils: Implications for Neutrophil-Platelet Interactions and Neutrophil Oxidative Burst

Platelets in Inflammation and Atherogenesis

The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation

The role of platelets in the recruitment of leukocytes during vascular disease

Platelets: bridging thrombosis and inflammation

Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation

Platelets: key players in vascular inflammation

Platelet-vessel wall interactions in atherosclerotic disease

Platelets and inter-cellular communication in immune responses: Dialogue with both professional and non-professional immune cells

Platelets, a Key Cell in Inflammation and Atherosclerosis Progression

Platelets, inflammation and atherosclerosis

Platelets in the NETworks interweaving inflammation and thrombosis

Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation

The rheology of interactions between leukocytes, platelets and the vessel wall in thrombo-inflammation

Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L

Platelets: Orchestrators of immunity in host defense and beyond

Platelet secretion in inflammatory and infectious diseases

The role of platelets in central hubs of inflammation: A literature review

Platelet-Leukocyte Interplay in Cancer Development and Progression

Platelet biology and functions: new concepts and clinical perspectives